The Short Seller Who Crushed Valeant Has Picked His Next Target - Bloomberg
Valeant: Yes, Ackman's a Loser. But How Much Did Short Sellers Make? | Barron's
Citron Research Report Is Out
Short seller Chanos says Tesla sure does remind him of Valeant
The Anti-Ackman: Valeant Short Sellers Have Made $2.8 Billion - Bloomberg
Valeant scandal shows why we need short-sellers in the stock market - Los Angeles Times
The Short Seller Who Crushed Valeant Has Picked His Next Target - Bloomberg
Short Seller Famous for Bet Against Valeant Targets Tesla - YouTube
The short seller who bet big against Valeant has turned bullish on the company he helped bring down - The Globe and Mail
Valeant warns of 'significant' short-term fallout
The Valeant saga: Why the world needs short sellers
Short Sellers Don't Exist to Fix the Problems. They Exist to Shed Light on the Problems” - ProMarket
Short-Seller Chanos Turns Attention to Valeant - The New York Times
Valeant shares plunge on short-seller scrutiny of pharmacy revenue | Reuters
Q&A with Safkhet's Fahmi Quadir: 'I love investigating frauds and making money at their expense'' - Financial News
Valeant scandal shows why we need short-sellers in the stock market - Los Angeles Times
Valeant shares recoup losses after company rejects short seller report - MarketWatch
The rise and fall of Valeant Pharmaceuticals | CBC News
Plunge In Valeant Pharmaceuticals Costs Top Five Shareholders, Including Ackman, Roughly $4bn
What the Average Short Position in Valeant
Valeant Pharmaceuticals' Dizzying Fall From Investors' Good Graces
Exclusive: SEC probe of Valeant began with review of short seller - sources | Reuters
Valeant's stock has plunged, so where are all the shorts? - The Globe and Mail
The short-seller who uncovered Valeant has found his next target in health care
Short seller who foresaw Valeant crash now bets on Tesla falling
Valeant's response to controversy is 'nonsense,' says short seller | Fortune
